Ferrari's Biggest Changes In Years Now Underway
Ferrari has laid the groundwork for some of the most significant changes it'll undergo in its 75-year histo...
Stay updated with breaking news from Chief Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ferrari has laid the groundwork for some of the most significant changes it'll undergo in its 75-year histo...
Share this article Share this article TEL AVIV, Israel, March 9, 2021 /PRNewswire/ -- SciSparc Ltd. (formerly known as Therapix Biosciences Ltd.) (OTCQB: SPRCY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced it has entered an agreement with The Sheba Fund for Health Services and Research, to perform a pre-clinical study for the evaluation of the Company's SCI-210 drug development program, a proprietary novel pharmaceutical preparation containing non-psychoactive cannabinoid cannabidiol (CBD)and palmitoylethan...